Stay updated with breaking news from Lantern Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
XCE853 is Oregon Therapeutic’s first-in-class, and potentially best-in-class PDI inhibitor, exhibiting potent preclinical efficacy across multiple solid and hematological cancers, and is ready to...
Q1 2024 Earnings Results & Corporate Updates Webcast to be held Thursday, May 9th, 4:30 p.m. ET, register for webcast here, or at the link provided below. ...
HC Wainwright reaffirmed their neutral rating on shares of Lantern Pharma (NASDAQ:LTRN – Free Report) in a research note published on Thursday morning, Benzinga reports. Lantern Pharma Stock Performance Shares of NASDAQ LTRN opened at $5.46 on Thursday. Lantern Pharma has a 12 month low of $2.38 and a 12 month high of $11.99. The […]
Webinar Wednesdays is planned to be held on the last Wednesday of each month - starting on Wednesday, April 24th with the first webinar on the increasing prevalence of non-small cell lung cancer in...
Global Camps Africa is pleased to announce that Dr. Anthony Fauci, renowned immunologist and public health advocate, was honored with the Sizanani Award at its annual gala event in Washington, DC on April 20th. The Sizanani Award, which translates...